LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 10 of 15: Cell count and normalized growth rate inhibition values within biological replicate 3. - Dataset (ID:20247)
Download: Excel (XLSX), Comma-separated (CSV)
Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | LJP Library Plate | Replicate | Assay Well | Timepoint | Timepoint Unit | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
MDA-MB-231 | SNS-032 | 10 | uM | LJP6 | 1 | H13 | 72 | hr | 1235 | 549 | 4355 | 0.1260 | -0.3602 |
MDA-MB-231 | SNS-032 | 10 | uM | LJP6 | 2 | H13 | 72 | hr | 1235 | 606 | 4277 | 0.1417 | -0.3283 |
MDA-MB-231 | SNS-032 | 10 | uM | LJP6 | 3 | H13 | 72 | hr | 1235 | 616 | 4583 | 0.1344 | -0.3081 |
MDA-MB-231 | Afatinib | 0.04 | uM | LJP6 | 1 | G24 | 72 | hr | 1235 | 3848 | 4355 | 0.8834 | 0.8681 |
MDA-MB-231 | Afatinib | 0.04 | uM | LJP6 | 2 | G24 | 72 | hr | 1235 | 4336 | 4277 | 1.0137 | 1.0153 |
MDA-MB-231 | Afatinib | 0.04 | uM | LJP6 | 3 | G24 | 72 | hr | 1235 | 4579 | 4583 | 0.9991 | 0.9990 |
MDA-MB-231 | Afatinib | 0.12 | uM | LJP6 | 1 | G23 | 72 | hr | 1235 | 4191 | 4355 | 0.9621 | 0.9580 |
MDA-MB-231 | Afatinib | 0.12 | uM | LJP6 | 2 | G23 | 72 | hr | 1235 | 3858 | 4277 | 0.9020 | 0.8880 |
MDA-MB-231 | Afatinib | 0.12 | uM | LJP6 | 3 | G23 | 72 | hr | 1235 | 4187 | 4583 | 0.9135 | 0.9066 |
MDA-MB-231 | Afatinib | 0.37 | uM | LJP6 | 1 | G22 | 72 | hr | 1235 | 3577 | 4355 | 0.8212 | 0.7945 |
MDA-MB-231 | Afatinib | 0.37 | uM | LJP6 | 2 | G22 | 72 | hr | 1235 | 3623 | 4277 | 0.8470 | 0.8229 |
MDA-MB-231 | Afatinib | 0.37 | uM | LJP6 | 3 | G22 | 72 | hr | 1235 | 3533 | 4583 | 0.7708 | 0.7428 |
MDA-MB-231 | Afatinib | 1.11 | uM | LJP6 | 1 | G21 | 72 | hr | 1235 | 2814 | 4355 | 0.6460 | 0.5726 |
MDA-MB-231 | Afatinib | 1.11 | uM | LJP6 | 2 | G21 | 72 | hr | 1235 | 2709 | 4277 | 0.6333 | 0.5498 |
MDA-MB-231 | Afatinib | 1.11 | uM | LJP6 | 3 | G21 | 72 | hr | 1235 | 2695 | 4583 | 0.5880 | 0.5103 |
MDA-MB-231 | Afatinib | 3.33 | uM | LJP6 | 1 | G20 | 72 | hr | 1235 | 2684 | 4355 | 0.6162 | 0.5322 |
MDA-MB-231 | Afatinib | 3.33 | uM | LJP6 | 2 | G20 | 72 | hr | 1235 | 2714 | 4277 | 0.6345 | 0.5514 |
MDA-MB-231 | Afatinib | 3.33 | uM | LJP6 | 3 | G20 | 72 | hr | 1235 | 2849 | 4583 | 0.6216 | 0.5553 |
MDA-MB-231 | Afatinib | 10 | uM | LJP6 | 1 | G19 | 72 | hr | 1235 | 577 | 4355 | 0.1325 | -0.3424 |
MDA-MB-231 | Afatinib | 10 | uM | LJP6 | 2 | G19 | 72 | hr | 1235 | 647 | 4277 | 0.1513 | -0.3033 |
MDA-MB-231 | Afatinib | 10 | uM | LJP6 | 3 | G19 | 72 | hr | 1235 | 662 | 4583 | 0.1444 | -0.2812 |
MDA-MB-231 | GSK1904529A | 0.04 | uM | LJP6 | 1 | H24 | 72 | hr | 1235 | 3805 | 4355 | 0.8735 | 0.8566 |
MDA-MB-231 | GSK1904529A | 0.04 | uM | LJP6 | 2 | H24 | 72 | hr | 1235 | 3985 | 4277 | 0.9317 | 0.9225 |
MDA-MB-231 | GSK1904529A | 0.04 | uM | LJP6 | 3 | H24 | 72 | hr | 1235 | 4082 | 4583 | 0.8906 | 0.8811 |
MDA-MB-231 | GSK1904529A | 0.12 | uM | LJP6 | 1 | H23 | 72 | hr | 1235 | 3953 | 4355 | 0.9075 | 0.8960 |